Survival Benefits of Complete Cytogenetic Response in Patients with Newly Diagnosed Myelodysplastic Syndrome

被引：0
|
作者：
Azevedo, Roberta Santos [1 ]
Kantarjian, Hagop M. [1 ]
Jabbour, Elias [1 ]
Kanagal-Shamanna, Rashmi [2 ]
Chien, Kelly S. [1 ]
Hammond, Danielle [1 ]
Urrutia, Samuel [1 ]
Bueso-Ramos, Carlos E. [2 ]
Patel, Keyur P. [2 ]
Montalban-Bravo, Guillermo [1 ]
Short, Nicholas J. [1 ]
Daver, Naval [1 ]
Borthakur, Gautam [1 ]
Kadia, Tapan M. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-201864
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6727 / 6727
页数：1
相关论文
共 50 条
  • [1] Impact of complete cytogenetic response on survival in patients with myelodysplastic syndromes.
    Urrutia, Samuel
    Sasaki, Koji
    Kantarjian, Hagop M.
    Jabbour, Elias
    Chien, Kelly Sharon
    Hammond, Danielle
    Bueso-Ramos, Carlos E.
    Khoury, Joseph
    Patel, Keyur P.
    Montalban-Bravo, Guillermo
    Wei, Yue
    Colla, Simona
    Short, Nicholas James
    Daver, Naval Guastad
    Borthakur, Gautam
    Kadia, Tapan M.
    Pierce, Sherry
    Wierda, William G.
    Garcia-Manero, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Cytogenetic Analysis in Patients with Newly Diagnosed Myelodysplastic Syndromes in Southern Italy
    Oliva, Esther Natalie
    Albano, Francesco
    Di Renzo, Nicola
    Pavone, Vincenzo
    Molica, Stefano
    Morabito, Fortunato
    Guarini, Attilio
    Tarantini, Giuseppe
    Capalbo, Silvana
    Iannitto, Emilio
    Quarta, Giovanni
    Cascavilla, Nicola
    Tassone, Pierfrancesco
    Iuliano, Francesco
    Porciello, Roberto
    Casieri, Paola
    Lagana, Carmelo
    Nobile, Francesco
    Specchia, Giorgina
    BLOOD, 2012, 120 (21)
  • [3] Machine Learning Prediction for Complete Response to Hypomethylating Agents with or without Additional Agents in Patients with Newly Diagnosed Myelodysplastic Syndrome
    Sasaki, Koji
    Bravo, Guillermo Montalban
    Kanagal-Shamanna, Rashmi
    Jabbour, Elias
    Ravandi, Farhad
    Kadia, Tapan M.
    Naqvi, Kiran
    Daver, Naval G.
    Pierce, Sherry A.
    Takahashi, Koichi
    DiNardo, Courtney D.
    Gonzalez, Graciela M. Nogueras
    Patel, Keyur
    Soltysiak, Kelly
    Sato, Junya
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    BLOOD, 2019, 134
  • [4] DISCONTINUATION OF HYPOMETHYLATING AGENT, DOES IT BRING REDUCED SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME?
    Lee, H. S.
    Kim, Y. S.
    Moon, J. H.
    Kim, H. J.
    Cheong, J. W.
    Jo, D. Y.
    Kim, H.
    Eom, H. S.
    Bang, S. M.
    Lee, W. S.
    Park, Y.
    Lee, M. H.
    Lee, J. H.
    Kim, M. K.
    HAEMATOLOGICA, 2016, 101 : 504 - 505
  • [5] CLINICAL, CYTOGENETIC AND SURVIVAL CHARACTERISTICS OF MYELODYSPLASTIC SYNDROME PATIENTS WITH POLYCYTHAEMIA
    Zhang, Yujiao
    Acton
    Steven
    Shad
    Liu, Jian
    Chen, Baili
    ACTA MEDICA MEDITERRANEA, 2020, 36 (06): : 3305 - +
  • [6] Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes
    Wang, Rong
    Gross, Cary P.
    Halene, Stephanie
    Ma, Xiaomei
    LEUKEMIA RESEARCH, 2009, 33 (12) : 1594 - 1598
  • [7] Clinical Outcomes of Patients with Newly Diagnosed Myelodysplastic Syndrome with MLL Aberrations
    Siddiqui, Maria
    Issa, Ghayas C.
    Sasaki, Koji
    Montalban-Bravo, Guillermo
    Chien, Kelly S.
    Jabbour, Elias J.
    Bueso-Ramos, Carlos E.
    Kanagal-Shamanna, Rashmi
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    BLOOD, 2021, 138
  • [8] Cytogenetic response to thalidomide treatment in three patients with myelodysplastic syndrome
    C Strupp
    B Hildebrandt
    U Germing
    R Haas
    N Gattermann
    Leukemia, 2003, 17 : 1200 - 1202
  • [9] Cytogenetic response to thalidomide treatment in three patients with myelodysplastic syndrome
    Strupp, C
    Hildebrandt, B
    Germing, U
    Haas, R
    Gattermann, N
    LEUKEMIA, 2003, 17 (06) : 1200 - 1202
  • [10] Impact of cytogenetic abnormalities on response to azacitidine in patients with myelodysplastic syndrome
    Iizuka, Hiroko
    Sugimoto, Keiji
    Takizawa, Haruko
    Wakabayashi, Mutsumi
    Sakajiri, Sakura
    Sekiguchi, Yasunobu
    Noguchi, Masaaki
    Komatsu, Norio
    ANNALS OF ONCOLOGY, 2019, 30
12345